Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group.

C Compton1, C M Fenoglio-Preiser, N Pettigrew

  • 1Massachusetts General Hospital Boston, Massachusetts, USA.

Cancer
|March 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of LIME-NZ: a generic tool for prompt estimation of economic impacts of disease for New Zealand livestock.

New Zealand veterinary journal·2024
Same author

Canadian Surgery Forum 2018: St. John's, NL Sept. 13-15, 2018.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial.

Respiratory research·2020
Same author

The Novartis view on emerging drugs and novel targets for the treatment of chronic obstructive pulmonary disease.

Pulmonary pharmacology & therapeutics·2013
Same author

Testing for her2 in breast cancer: current pathology challenges faced in Canada.

Current oncology (Toronto, Ont.)·2013
Same author

Determination of foetal sex in pregnancies at risk of haemophilia: a qualitative study exploring the clinical practices and attitudes of health professionals in the United Kingdom.

Haemophilia : the official journal of the World Federation of Hemophilia·2011
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
Same journal

Maintenance therapy in gynecologic malignancies: Current and future state.

Cancer·2026
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
See all related articles

Updated TNM staging for colorectal cancer refines T categories and incorporates carcinoembryonic antigen (CEA) levels for improved patient stratification. Appendix cancer is now excluded from this staging system.

Area of Science:

  • Oncology
  • Cancer Staging
  • Clinical Research

Background:

  • The American Joint Committee on Cancer (AJCC) established a working party to update recommendations for colorectal carcinoma staging.
  • Existing TNM staging systems undergo regular review to incorporate advancements in cancer research and clinical practice.

Framework:

  • A consensus conference developed a prognostic marker value classification system (Category I-IV) to guide recommendations.
  • This framework utilizes published literature and expert consensus to inform staging updates.

Implementation:

  • Key T categories (pTis, pT1, pT4) were subdivided for greater precision.
  • Serum carcinoembryonic antigen (CEA) levels were recommended for inclusion in TNM staging.
  • Carcinoma of the appendix was excluded from the colorectal staging system due to distinct biological behavior.

Related Experiment Videos

Implications:

  • Refined TNM categories enhance prognostic discrimination for individual colorectal cancer patients.
  • Inclusion of CEA levels provides an additional objective measure for staging.
  • These updates aim to improve the clinical utility and accuracy of colorectal cancer staging.